WallStreetZenWallStreetZen

NASDAQ: MAZE
Maze Therapeutics Inc Stock Ownership - Who owns Maze Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maze Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jason V. ColomaCEO2026-11-025,345$31.05
$165.98kSell
Jason V. ColomaCEO2026-11-02336$30.91
$10.39kSell
Jason V. ColomaCEO2026-11-022,257$30.12
$67.99kSell
Jason V. ColomaCEO2026-11-0226,563$30.10
$799.41kSell
Atul DandekarOfficer2026-10-297,500$32.07
$240.53kSell
Atul DandekarOfficer2026-10-29857$10.42
$8.93kBuy
Atul DandekarOfficer2026-10-296,643$10.42
$69.22kBuy
Harold BernsteinPres;CMO2026-10-0116,141$10.42
$168.19kBuy
Jason V. ColomaCEO2026-10-0131,908$27.02
$862.19kSell
Jason V. ColomaCEO2026-10-012,593$27.02
$70.07kSell

1 of 15

MAZE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MAZE insiders and whales buy or sell their stock.

MAZE Shareholders

What type of owners hold Maze Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Third Rock Ventures IV LP9.77%5,424,758$185.47MInsider
Jonathan E. Lim0.59%328,700$11.24MInsider
Jason V. Coloma0.41%227,228$7.77MInsider
Sekar Kathiresan0.19%103,723$3.55MInsider
Charles J. Homcy0.07%38,535$1.32MInsider
Atul Dandekar0.06%32,316$1.10MInsider
Amy Bachrodt0.02%12,965$443.27kInsider
Phillips Courtney0.01%7,007$239.57kInsider
Frazls0.01%5,033$172.08kInstitution
Frazier Life Sciences Management LP0.01%5,032$172.04kInstitution

1 of 3

MAZE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MAZE0.11%11.12%Net SellingNet Selling
SRPT0.10%28.93%Net SellingNet Selling
VCYT0.11%53.41%Net SellingNet Selling
HRMY0.09%25.29%Net SellingNet Selling
MESO0.00%19.07%Net Buying
View Top Biotech Stocks

Maze Therapeutics Stock Ownership FAQ

Who owns Maze Therapeutics?

Maze Therapeutics (NASDAQ: MAZE) is owned by 0.11% institutional shareholders, 11.12% Maze Therapeutics insiders, and 88.78% retail investors. Third Rock Ventures IV LP is the largest individual Maze Therapeutics shareholder, owning 5.42M shares representing 9.77% of the company. Third Rock Ventures IV LP's Maze Therapeutics shares are currently valued at $185.47M.

If you're new to stock investing, here's how to buy Maze Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.